| Literature DB >> 25522786 |
Victor L Fulgoni, Sanjiv Agarwal1, Lisa Spence, Priscilla Samuel.
Abstract
BACKGROUND: Because excessive dietary sodium intake is a major contributor to hypertension, a reduction in dietary sodium has been recommended for the US population. Using the National Health and Nutrition Examination Survey (NHANES) 2007-2010 data, we estimated current sodium intake in US population ethnic subgroups and modeled the potential impact of a new sodium reduction technology on sodium intake.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25522786 PMCID: PMC4290401 DOI: 10.1186/1475-2891-13-120
Source DB: PubMed Journal: Nutr J ISSN: 1475-2891 Impact factor: 3.271
Figure 1Usual intake of sodium by age and gender groups in population subgroups. Data from NHANES 2007–2010. Usual intakes from foods were estimated by using the National Cancer Institute method. *Dietary Guidelines for Americans 2010 recommended level for general population; **Dietary Guidelines for Americans 2010 recommended level for at risk group.
Figure 2Sodium intake trends by age and gender groups over 5 NHANES cycles in population subgroups. Data from NHANES 2001–2010. Square: male, Circles: females, solid line: 19–50 years, dotted line: 51 + years. Usual intakes from foods were estimated by using the National Cancer Institute method. *No change over 5 NHANES cycles, P > 0.01.
Sodium intake trends by age and gender groups in population subgroups over 5 NHANES cycles
| Ethnicity | Age (Years) | Gender | Sodium intake trend | |||||
|---|---|---|---|---|---|---|---|---|
| mg/day | mg/g food | mg/kcal | ||||||
| beta* | P** | beta* | P** | beta* | P** | |||
| Mexican American | 19-50 | Male | −19.33 | 0.7652 | −0.10 | <0.0001 | 0.03 | 0.0342 |
| Female | −34.38 | 0.2673 | −0.14 | <0.0001 | 0.02 | 0.0544 | ||
| 51+ | Male | −39.13 | 0.4792 | −0.09 | <0.0001 | −0.01 | 0.5585 | |
| Female | 53.75 | 0.1116 | −0.13 | <0.0001 | 0.02 | 0.1729 | ||
| Other Hispanic | 19-50 | Male | 110.83 | 0.0913 | −0.10 | <0.0001 | 0.04 | 0.0327 |
| Female | 63.23 | 0.1697 | −0.12 | 0.0004 | 0.04 | 0.0635 | ||
| 51+ | Male | 91.07 | 0.4067 | −0.11 | 0.0508 | 0.03 | 0.4286 | |
| Female | 26.09 | 0.6285 | −0.14 | <0.0001 | 0.03 | 0.1452 | ||
| Non-Hispanic White | 19-50 | Male | 23.42 | 0.5281 | −0.12 | <0.0001 | 0.03 | 0.0012 |
| Female | −34.81 | 0.1798 | −0.15 | <0.0001 | 0.01 | 0.2341 | ||
| 51+ | Male | 29.05 | 0.3438 | −0.11 | <0.0001 | 0.00 | 0.6550 | |
| Female | −13.25 | 0.4582 | −0.13 | <0.0001 | −0.01 | 0.1134 | ||
| Non-Hispanic Black | 19-50 | Male | −59.10 | 0.2367 | −0.14 | <0.0001 | 0.02 | 0.1816 |
| Female | −18.59 | 0.6458 | −0.19 | <0.0001 | 0.02 | 0.0936 | ||
| 51+ | Male | 100.06 | 0.0619 | −0.12 | <0.0001 | −0.02 | 0.3977 | |
| Female | 56.50 | 0.1167 | −0.14 | <0.0001 | 0.03 | 0.0242 | ||
Data from NHANES 2001–2010. Sodium intake was measured as absolute intake (mg/day) as a function of energy intake (mg/kcal) and as a function of food intake (mg/g food).
*beta – regression coefficient; **P < 0.01 significant.
Figure 3Dietary sodium contribution from nine FNDDS food groups by age groups in population subgroups. Data from NHANES 2007–2010. Data is presented as % of total dietary sodium.
Potential sodium intake reduction with SODA-LO® Salt Microspheres (Sodium Replacement Technology) in population subgroups
| Ethnicity | Age | Potential reduction* (mg) | Current intake (mg) | Potential intake after reduction (mg) | % Reduction* |
|---|---|---|---|---|---|
| Mexican American | 19-50 years | 250 ± 14 | 3558 ± 68 | 3309 ± 59 | 6.8 ± 0.3 |
| 51+ years | 196 ± 12 | 2898 ± 86 | 2702 ± 78 | 6.8 ± 0.4 | |
| Other Hispanic | 19-50 years | 252 ± 11 | 3599 ± 45 | 3347 ± 39 | 6.9 ± 0.3 |
| 51+ years | 185 ± 11 | 2916 ± 68 | 2731 ± 63 | 6.3 ± 0.3 | |
| Non-Hispanic White | 19-50 years | 323 ± 8 | 3903 ± 55 | 3581 ± 53 | 8.3 ± 0.2 |
| 51+ years | 242 ± 5 | 3320 ± 49 | 3078 ± 47 | 7.3 ± 0.2 | |
| Non-Hispanic Black | 19-50 years | 296 ± 10 | 3544 ± 66 | 3248 ± 60 | 8.4 ± 0.2 |
| 51+ years | 222 ± 9 | 3046 ± 74 | 2824 ± 67 | 7.2 ± 0.2 |
Data from NHANES 2007–2010. Potential reduction was modeled using 20% to 30% targeted maximum reduction in sodium content in 953 foods with 100% market penetration.
*Average of reductions in individuals.
Potential sodium intake reduction with SODA-LO® salt microspheres in population subgroups by FNDDS food groups
| Potential sodium intake reduction, mg & (%) | ||||
|---|---|---|---|---|
| Mean ± SE | ||||
| Mexican American | Other Hispanic | Non-Hispanic white | Non-Hispanic black | |
|
| ||||
| Male, 19–50 Years | 294 ± 20 (6.9 ± 0.4) | 297 ± 15 (7.0 ± 0.3) | 398 ± 13 (8.7 ± 0.2) | 338 ± 13 (8.3 ± 0.3) |
| Male, 51+ Years | 236 ± 19 (7.3 ± 0.5) | 222 ± 18 (6.7 ± 0.5) | 290 ± 7 (7.4 ± 0.2) | 258 ± 14 (7.2 ± 0.2) |
| Female, 19–50 Years | 193 ± 10 (6.7 ± 0.3) | 198 ± 9 (6.8 ± 0.3) | 248 ± 7 (8.0 ± 0.2) | 259 ± 14 (8.4 ± 0.3) |
| Female 51+ Years | 161 ± 7 (6.3 ± 0.3) | 152 ± 7 (6.0 ± 0.3) | 200 ± 6 (7.2 ± 0.2) | 195 ± 12 (7.2 ± 0.3) |
|
| ||||
| Male, 19–50 Years | 2 ± 1 (0.2 ± 0.1) | 2 ± 1 (0.2 ± 0.1) | 4 ± 1 (0.3 ± 0.1) | 0.3 ± 0.2 (0.1 ± 0.0) |
| Male, 51+ Years | 0.2 ± 0.1 (0.02 ± 0.01) | 0.3 ± 0.2 (0.1 ± 0.0) | 5 ± 1 (0.5 ± 0.1) | 1 ± 0 (0.2 ± 0.2) |
| Female, 19–50 Years | 2 ± 1 (0.4 ± 0.2) | 2 ± 1 (0.3 ± 0.1) | 5 ± 1 (0.5 ± 0.1) | 2 ± 1 (0.4 ± 0.1) |
| Female 51+ Years | 5 ± 2 (0.6 ± 0.2) | 3 ± 1 (0.4 ± 0.1) | 6 ± 1 (0.9 ± 0.1) | 2 ± 1 (0.4 ± 0.2) |
|
| ||||
| Male, 19–50 Years | 67 ± 9 (4.7 ± 0.5) | 72 ± 9 (4.8 ± 0.4) | 87 ± 5 (5.5 ± 0.3) | 117 ± 7 (7.4 ± 0.3) |
| Male, 51+ Years | 44 ± 6 (4.4 ± 0.6) | 39 ± 6 (3.9 ± 0.5) | 59 ± 4 (4.5 ± 0.2) | 79 ± 5 (5.5 ± 0.3) |
| Female, 19–50 Years | 44 ± 7 (5.1 ± 0.6) | 43 ± 5 (4.9 ± 0.5) | 53 ± 4 (5.8 ± 0.4) | 92 ± 7 (8.2 ± 0.5) |
| Female 51+ Years | 37 ± 6 (4.8 ± 0.5) | 31 ± 5 (3.9 ± 0.5) | 31 ± 3 (3.9 ± 0.3) | 49 ± 5 (5.0 ± 0.5) |
|
| ||||
| Male, 19–50 Years | 4 ± 2 (1.2 ± 0.5) | 3 ± 1 (1.0 ± 0.4) | 4 ± 1 (1.6 ± 0.4) | 4 ± 2 (1.2 ± 0.5) |
| Male, 51+ Years | 2 ± 1 (0.4 ± 0.3) | 1 ± 1 (0.3 ± 0.3) | 5 ± 1 (2.0 ± 0.5) | 4 ± 1 (1.0 ± 0.4) |
| Female, 19–50 Years | 3 ± 1 (1.3 ± 0.5) | 3 ± 1 (1.3 ± 0.4) | 3 ± 1 (2.1 ± 0.7) | 4 ± 2 (2.0 ± 0.7) |
| Female 51+ Years | 2 ± 1 (0.6 ± 0.3) | 1 ± 1 (0.4 ± 0.2) | 2 ± 1 (0.7 ± 0.3) | 3 ± 2 (0.7 ± 0.4) |
|
| ||||
| Male, 19–50 Years | 5 ± 1 (3.3 ± 0.6) | 4 ± 1 (3.0 ± 0.5) | 7 ± 1 (9.6 ± 0.8) | 3 ± 0.7 (8.4 ± 0.9) |
| Male, 51+ Years | 4 ± 1 (4.3 ± 0.9) | 3 ± 1 (4.1 ± 0.8) | 8 ± 1 (10.7 ± 0.8) | 4 ± 1 (6.6 ± 1.0) |
| Female, 19–50 Years | 2 ± 1 (4.0 ± 0.7) | 2 ± 0.4 (4.6 ± 0.6) | 5 ± 1 (8.0 ± 0.7) | 2 ± 0.5 (7.4 ± 1.3) |
| Female 51+ Years | 2 ± 1 (4.1 ± 0.9) | 3 ± 1 (5.1 ± 0.8) | 5 ± 0.4 (11.1 ± 0.8) | 2 ± 0.4 (7.3 ± 1.0) |
|
| ||||
| Male, 19–50 Years | 195 ± 16 (13.4 ± 0.8) | 195 ± 13 (12.6 ± 0.6) | 253 ± 11 (15.1 ± 0.4) | 179 ± 10 (13.0 ± 0.4) |
| Male, 51+ Years | 166 ± 13 (14.7 ± 0.6) | 158 ± 13 (13.4 ± 0.6) | 176 ± 6 (14.4 ± 0.4) | 145 ± 12 (13.4 ± 0.5) |
| Female, 19–50 Years | 125 ± 5 (11.2 ± 0.3) | 132 ± 6 (11.3 ± 0.4) | 156 ± 5 (14.0 ± 0.2) | 126 ± 8 (11.5 ± 0.5) |
| Female 51+ Years | 99 ± 6 (11.6 ± 0.6) | 100 ± 4 (11.4 ± 0.5) | 132 ± 5 (14.1 ± 0.3) | 117 ± 7 (13.3 ± 0.5) |
|
| ||||
| Male, 19–50 Years | 18 ± 2 (5.0 ± 0.4) | 17 ± 2 (5.0 ± 0.4) | 37 ± 3 (7.1 ± 0.4) | 29 ± 3 (8.5 ± 0.7) |
| Male, 51+ Years | 15 ± 2 (4.7 ± 0.6) | 14 ± 2 (4.6 ± 0.4) | 25 ± 2 (4.7 ± 0.3) | 18 ± 2 (4.3 ± 0.4) |
| Female, 19–50 Years | 15 ± 1 (4.4 ± 0.4) | 14 ± 1 (5.0 ± 0.4) | 20 ± 1 (5.8 ± 0.4) | 28 ± 3 (7.8 ± 0.6) |
| Female 51+ Years | 12 ± 2 (3.6 ± 0.7) | 10 ± 2 (3.3 ± 0.5) | 16 ± 1 (3.9 ± 0.3) | 17 ± 2 (5.3 ± 0.6) |
|
| ||||
| Male, 19–50 Years | 4 ± 1 (16.1 ± 1.3) | 4 ± 0 (16.4 ± 1.0) | 7 ± 1 (14.4 ± 0.9) | 5 ± 1 (14.4 ± 0.9) |
| Male, 51+ Years | 4 ± 1 (6.0 ± 1.6) | 6 ± 1 (15.8 ± 1.3) | 12 ± 1 (15.5 ± 0.6) | 8 ± 1 (18.6 ± 0.9) |
| Female, 19–50 Years | 2 ± 0 (11.5 ± 1.0) | 3 ± 0 (12.0 ± 0.8) | 6 ± 1 (13.5 ± 0.7) | 4 ± 1 (13.4 ± 1.2) |
| Female 51+ Years | 4 ± 1 (16.1 ± 0.8) | 4 ± 1 (15.6 ± 0.8) | 9 ± 1 (13.6 ± 0.6) | 6 ± 1(16.4 ± 0.8) |
Data from NHANES 2007–2010. Potential reduction was modeled using 20% to 30% targeted maximum reduction in sodium content in 953 foods with 100% market penetration.